Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

TSC22D3 Knockout Jurkat E6.1 Cell Line

CRISPR/Cas9-edited TSC22D3 knockout Jurkat E6.1 cell line from human acute T-cell leukemia disrupts the glucocorticoid-induced leucine zipper (GILZ) transcriptional repressor. GILZ normally binds NF-??B p65…
Cat. No. ARG44200

TRU-TCA1-1 Knockout THP-1 Cell Line

The TRU-TCA1-1 Knockout THP-1 Cell Line is a CRISPR/Cas9-edited knockout cell line with disrupted TRU-TCA1-1 in human THP-1 monocytic leukemia cells. TRU-TCA1-1 encodes a mitochondrial…
Cat. No. ARG44199

TRPV6 Knockout PANC-1 Cell Line

The TRPV6 Knockout PANC-1 Cell Line is a CRISPR/Cas9-edited knockout cell line in the PANC-1 human pancreatic ductal adenocarcinoma background. Disruption of TRPV6, a highly…
Cat. No. ARG44198

TRPM2 Knockout HaCaT Cell Line

The TRPM2 Knockout HaCaT Cell Line is a CRISPR/Cas9-edited human keratinocyte line lacking functional TRPM2, a calcium-permeable cation channel activated by ADP-ribose and oxidative stress.…
Cat. No. ARG44197

Trp53 Knockout ID8 Cell Line

The Trp53 Knockout ID8 Cell Line is a CRISPR/Cas9-edited knockout cell line from the C57BL/6 mouse ovarian surface epithelial ID8 line, used for ovarian cancer…
Cat. No. ARG44196

Trp53 Knockout C57BL/6 MSC Cell Line

The Trp53 Knockout C57BL/6 MSC Cell Line is a CRISPR/Cas9-edited knockout of the Trp53 gene in C57BL/6 mouse mesenchymal stem cells. Trp53 encodes the p53…
Cat. No. ARG44195

TRMT10A Knockout A-673 Cell Line

The TRMT10A Knockout A-673 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the A-673 rhabdomyosarcoma cell line. It disrupts TRMT10A, a tRNA methyltransferase…
Cat. No. ARG44194

TRIM8 Knockout Hep-G2 Cell Line

The TRIM8 Knockout Hep-G2 Cell Line provides a CRISPR/Cas9-edited loss-of-function model of TRIM8, an E3 ubiquitin ligase that controls NF-??B and JAK-STAT pathways, in the…
Cat. No. ARG44193

TRIM7 Knockout A549 Cell Line

The TRIM7 Knockout A549 Cell Line is a CRISPR/Cas9-edited human lung adenocarcinoma cell line lacking functional TRIM7, an E3 ubiquitin ligase that targets STING and…
Cat. No. ARG44192

TRIM47 Knockout HuH-7 Cell Line

The TRIM47 Knockout HuH-7 Cell Line is a CRISPR/Cas9-edited loss-of-function model in a well-differentiated hepatocellular carcinoma background, with targeted disruption of the TRIM47 gene. TRIM47…
Cat. No. ARG44191

TRIM24 Knockout A549 Cell Line

The TRIM24 Knockout A549 Cell Line is a CRISPR/Cas9-edited human cell line that disrupts TRIM24 expression, a gene encoding an E3 ubiquitin ligase involved in…
Cat. No. ARG44190

Trim21 Knockout BV-2 Cell Line

The Trim21 Knockout BV-2 Cell Line is a CRISPR/Cas9-edited loss-of-function model in mouse microglial cells. Disruption of Trim21, an E3 ubiquitin ligase, impairs antibody-mediated pathogen…
Cat. No. ARG44189

Loading products...